Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia

With emerging amyloid therapies, documentation of the patient's amyloid status to confirm the etiology of a clinical diagnosis is warranted prior to instituting amyloid-based therapy. The Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) is a noninvasive blood-based biomarker utilized to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominguez, Jacqueline Cotoong, Yu, Jeryl Ritzi Tan, De Guzman, Ma Fe, Ampil, Encarnita, Guevarra, Anne Cristine, Joson, Ma. Lourdes, Reandelar, Macario, Martinez, Ma. Socorro, Ligsay, Antonio, Ocampo, Ferron, Kim, SangYun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085320/
https://www.ncbi.nlm.nih.gov/pubmed/35547155
http://dx.doi.org/10.1155/2022/9960832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085320/
https://www.ncbi.nlm.nih.gov/pubmed/35547155
http://dx.doi.org/10.1155/2022/9960832

Ejemplares similares